Hermetica Superfood Encyclopedia
The Short Answer
Pleurotus ferulae contains polysaccharides, cytotoxic proteins, lecithins, and medium-to-long-chain fatty acids that modulate lipid metabolism, exert free-radical scavenging activity, and promote antiproliferative signaling in tumor cell lines. In a rat hypercholesterolemia model, dietary supplementation at 5% reduced LDL cholesterol by 71.15%, total cholesterol by 30.02%, and triglycerides by 49.31%, representing the most quantitatively robust preclinical efficacy data available.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordPleurotus ferulae benefits
Ferula Oyster Mushroom — botanical close-up
Health Benefits
**Antihyperlipidemic Activity**
Bioactive polysaccharides and fatty acids act on lipid metabolism pathways, producing significant reductions in total cholesterol (30.02%), triglycerides (49.31%), and LDL (71.15%) in rat dietary models at a 5% supplementation level.
**Antioxidant Protection**
Medium-to-long-chain fatty acids and phenolic compounds found in ethanol extracts scavenge reactive oxygen species, contributing to measurable free-radical neutralization activity distinct from water-soluble fractions.
**Antitumor and Antiproliferative Effects**
Proteins and peptides within the fruiting body bind membrane polysaccharides on tumor cell surfaces to trigger cytotoxic and antiproliferative cascades, with activity documented in melanoma cell models both in vitro and in vivo.
**Immunomodulatory Support**
Lecithin fractions and specific proteins within Pleurotus ferulae have demonstrated immunomodulatory properties, potentially regulating innate immune responses through macrophage and lymphocyte activation pathways.
**Hepatoprotective Potential**
Rat dietary studies observed reductions in plasma GOT (14.69%), GPT (13.41%), and ALP (5.19%) activity following P. ferulae supplementation, suggesting attenuation of hepatic enzyme elevation associated with hyperlipidemia-induced liver stress.
**Anti-Obesity Effects**
Water extracts have shown anti-adipogenic activity in 3T3-L1 adipocyte cell models, inhibiting lipid accumulation during differentiation, though quantitative effect sizes from these studies remain incompletely reported in peer-reviewed literature.
**Ergothioneine Contribution**: As a member of the Pleurotus genus, P
ferulae is recognized as a dietary source of ergothioneine, a naturally occurring thiohistidine amino acid with potent cytoprotective and antioxidant properties that accumulates selectively in human tissues expressing the OCTN1 transporter.
Origin & History
Natural habitat
Pleurotus ferulae is native to arid and semi-arid regions of Central Asia, the Mediterranean basin, and northwestern China, where it grows saprophytically on the decaying roots and stems of giant fennel (Ferula spp.) plants. It thrives in dry, steppe-like environments at elevations ranging from lowland plains to mountain foothills, fruiting seasonally in autumn and early spring. The mushroom has been commercially cultivated in China and parts of the Middle East, where it is harvested for both culinary consumption and ethnomedicinal use.
“Pleurotus ferulae has been consumed as a food and folk medicine in Central Asian and Middle Eastern cultures for centuries, valued for its nutritional density and purported health-promoting properties in regions where Ferula plants are abundant. In northwestern China and parts of the Xinjiang region, the mushroom holds particular cultural significance as a seasonal delicacy and traditional remedy associated with vitality and digestive health. It is referenced in ethnobotanical literature as one of the edible wild Pleurotus species used for both nutritional sustenance and informal medicinal preparations, though detailed pharmacopeial records or classical medical text citations are not widely documented in Western scientific literature. The mushroom's association with the Ferula plant—itself historically significant in Mediterranean and Persian medicine as a source of asafoetida resin—has contributed to its regional recognition as an ingredient with presumed medicinal properties beyond simple nutrition.”Traditional Medicine
Scientific Research
The current evidence base for Pleurotus ferulae consists exclusively of in vitro cell studies and in vivo animal model experiments; no peer-reviewed human clinical trials have been published as of the available literature. A rat hypercholesterolemia study demonstrated statistically significant lipid-lowering effects at 5% dietary incorporation, with LDL reduction of 71.15% representing the most quantitatively compelling preclinical finding. Anti-tumor effects have been investigated in melanoma models using 95% ethanol extracts, and anti-obesity potential has been assessed in 3T3-L1 adipocyte differentiation assays, though detailed quantitative outcomes from these studies are not fully reported in accessible sources. The overall evidence quality is rated as preliminary; translational validity to human populations cannot be assumed without dose-ranging pharmacokinetic studies, bioavailability assessments, and controlled human trials.
Preparation & Dosage
Traditional preparation
**Dried Fruiting Body Powder (Animal Studies)**
5% dietary incorporation used in rat models; no equivalent human dosage established
**Ethanol Extract (95% v/v)**
Prepared by macerating fresh fruiting bodies three times in 95% ethanol at 50°C for 3 hours followed by 30-minute sonication at 300 W; used in antitumor in vitro and in vivo studies
**Water Extract (PWE)**
Aqueous extraction yields polysaccharide-rich fractions (662.2 µg gallic acid equivalents/mg dried weight); note that phenolics and flavonoids are largely undetectable in water extracts, indicating extract-type-dependent bioactive profiles
**Culinary Preparation**
Traditionally consumed as fresh or dried cooked mushroom in Asian cuisine; standard culinary quantities are not standardized for therapeutic endpoints
**Standardization**
No commercial standardization benchmarks for polysaccharide content, ergothioneine concentration, or specific bioactive fractions have been established in peer-reviewed sources
**Timing and Form Notes**
Bioavailability data for any extract form are absent from published literature; optimal dosing frequency, timing relative to meals, and formulation type for human use remain undetermined
Nutritional Profile
Pleurotus ferulae fruiting bodies provide a nutritional profile typical of the Pleurotus genus: high protein content with a favorable essential amino acid spectrum, low fat, and moderate carbohydrate content predominantly as dietary fiber and beta-glucan polysaccharides. Water extracts yield polysaccharide concentrations of approximately 662.2 µg gallic acid equivalents per mg of dried weight, indicating a substantial polysaccharide load in aqueous preparations. Organic acid constituents identified by HPLC-MS include citric, succinic, and fumaric acids, contributing to its acidic flavor profile and potential metabolic effects. The mushroom is recognized as a dietary source of ergothioneine—a stable, heat-resistant thiohistidine antioxidant amino acid—though species-specific ergothioneine quantification for P. ferulae has not been published separately from broader Pleurotus genus analyses. Phenolic compounds and flavonoids are detectable in ethanol extracts but largely absent in water extracts, highlighting the critical role of extraction methodology in determining bioactive compound availability and bioavailability.
How It Works
Mechanism of Action
Pleurotus ferulae polysaccharides modulate lipid metabolism by interfering with hepatic cholesterol biosynthesis and enhancing LDL receptor-mediated clearance, contributing to the pronounced reductions in atherogenic lipid fractions observed in animal models. Cytotoxic proteins and lectins within the fruiting body interact with glycoprotein receptors on tumor cell membranes, initiating apoptotic cascades and suppressing proliferative signaling, while lecithin components are implicated in membrane-level immunomodulatory activity. Medium-to-long-chain fatty acid constituents and phenolic compounds identified via HPLC-MS—including organic acids such as citric, succinic, and fumaric acid—contribute to antioxidant activity through direct free-radical scavenging and potential modulation of oxidative stress-response enzymes. Specific intracellular signal transduction pathways, receptor binding affinities, and gene expression targets have not yet been characterized at the molecular level in published literature, representing a significant gap in mechanistic understanding.
Clinical Evidence
No human clinical trials investigating Pleurotus ferulae as a dietary supplement or therapeutic agent have been identified in the published literature. Preclinical efficacy data derive from a rat dietary model of hypercholesterolemia, in vitro melanoma cytotoxicity assays, and a 3T3-L1 adipocyte anti-obesity model, none of which provide direct evidence of clinical benefit in humans. The most specific quantitative outcomes—30.02% reduction in total cholesterol, 49.31% reduction in triglycerides, and 71.15% reduction in LDL—were obtained from a controlled animal feeding study at a 5% mushroom diet incorporation level, a dose not directly translatable to human supplementation protocols. Confidence in clinical extrapolation remains low, and formal randomized controlled trials with defined endpoints, safety monitoring, and standardized extract preparations are required to establish therapeutic utility.
Safety & Interactions
No formal toxicology studies, adverse event reports, or safety threshold data for Pleurotus ferulae extracts or supplements have been published in peer-reviewed literature, representing a significant evidence gap for consumer safety assessment. The mushroom has a long history of culinary consumption in Asia without documented reports of widespread adverse effects, suggesting reasonable food-level safety, though this does not establish the safety of concentrated extracts or high-dose supplements. No drug interaction studies have been conducted; however, given its documented lipid-lowering activity in animal models, theoretical caution is warranted when co-administering with HMG-CoA reductase inhibitors (statins), fibrates, or other antihyperlipidemic agents due to potential additive effects on lipid metabolism. Specific contraindications, pregnancy and lactation guidance, and maximum safe doses cannot be established from available data, and individuals with mushroom allergies, immunocompromised status, or those taking anticoagulant medications should consult a healthcare provider before use.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Pleurotus ferulae SingerFerula Oyster MushroomFerula PleurotusBailinggu (Chinese: 百灵菇)Eryngii-type oyster mushroom variant
Frequently Asked Questions
What is Pleurotus ferulae used for?
Pleurotus ferulae is used primarily for its antihyperlipidemic, antioxidant, and antitumor properties documented in preclinical research. Animal studies show it can reduce LDL cholesterol by over 71% and triglycerides by nearly 50% at dietary supplementation levels, while in vitro studies suggest antiproliferative activity against melanoma cells. It is also consumed as an edible mushroom in Asian cuisine, particularly in China and Central Asia.
Does Pleurotus ferulae contain ergothioneine?
Yes, Pleurotus ferulae is recognized as a dietary source of ergothioneine, a naturally occurring thiohistidine amino acid with potent cytoprotective and antioxidant activity found across the Pleurotus genus. Ergothioneine accumulates in human tissues via the OCTN1 transporter and is not synthesized by mammals, making dietary mushroom sources such as P. ferulae important contributors to ergothioneine intake. Species-specific ergothioneine quantification for P. ferulae has not yet been separately reported in published literature.
Are there human clinical trials on Pleurotus ferulae?
No human clinical trials investigating Pleurotus ferulae have been published in the peer-reviewed literature as of available sources. All efficacy data derive from animal models—primarily rat dietary studies and in vitro cell assays—which cannot be directly extrapolated to human dosing or clinical outcomes. Formal controlled trials with standardized extracts, defined endpoints, and pharmacokinetic assessments are needed before therapeutic recommendations can be made.
What are the side effects of Pleurotus ferulae supplements?
No formal safety or toxicology studies for Pleurotus ferulae extracts or supplements have been published, so a comprehensive side effect profile cannot be established. The mushroom has been consumed culinarily in Asian regions without widespread documented adverse effects, suggesting general food-level tolerability. Individuals with mushroom hypersensitivity, those taking lipid-lowering medications such as statins, or immunocompromised individuals should seek medical guidance before using concentrated supplements.
What is the recommended dosage of Pleurotus ferulae?
No standardized human dosage for Pleurotus ferulae has been established, as all efficacy data derive from animal studies using 5% dietary incorporation of the dried fruiting body. This animal-model dose cannot be directly converted to a human equivalent without formal pharmacokinetic and dose-ranging studies. Commercial extract preparations are not standardized to specific bioactive markers such as polysaccharide content or ergothioneine concentration, making evidence-based dosing recommendations premature.
How does Pleurotus ferulae compare to other oyster mushroom species for cholesterol management?
Pleurotus ferulae demonstrates particularly potent antihyperlipidemic effects, with studies showing reductions in total cholesterol (30.02%), triglycerides (49.31%), and LDL cholesterol (71.15%) at 5% dietary supplementation in animal models. While other Pleurotus species contain bioactive compounds, P. ferulae's specific fatty acid and polysaccharide profile appears optimized for lipid metabolism modulation. Direct comparative studies between P. ferulae and other oyster mushroom varieties are limited, making it difficult to definitively rank its superiority for this application.
What forms of Pleurotus ferulae extract provide the best antioxidant activity?
Ethanol extracts of Pleurotus ferulae have demonstrated superior antioxidant capacity due to their ability to concentrate phenolic compounds and medium-to-long-chain fatty acids that effectively scavenge reactive oxygen species. The extraction method significantly influences bioactive compound retention, with solvent-based extraction generally preserving more phenolic content than water or hot-water extraction alone. Standardized ethanol extracts may offer more consistent antioxidant potency compared to whole mushroom powders, though this depends on extraction parameters and standardization protocols.
Is Pleurotus ferulae suitable for individuals with existing cardiovascular disease or those taking lipid-lowering medications?
While Pleurotus ferulae's significant effects on cholesterol and triglyceride reduction suggest potential cardiovascular benefits, individuals with existing cardiovascular disease or taking statins and other lipid-lowering medications should consult healthcare providers before supplementation to avoid additive hyperlipidemic effects. The potency of P. ferulae in animal models (71.15% LDL reduction) suggests it could interact meaningfully with prescription medications. Medical supervision is particularly important given the lack of human clinical trials establishing safe concurrent use with pharmaceutical lipid-management agents.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w pleurotus-ferulae-pleurotus-ferulae-singer curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
